• My Son’s Birth Led to the Discovery of a Family Secret
  • Hemlibra Ably Treats Hemophilia A Patients Regardless of Inhibitor Status, Data from 2 Phase 3 Trials Show
  • Patient Advocacy Groups Focus on Key Issues Affecting Hemophilia in 5 States
  • Finding Answers Together
  • ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
  • National Camp Exchange, Program for Hemophilia Camp Leaders, Now Taking Applications
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • Despite Hemophilia Joint Damage, New Treatment Opens Up Possibilities
  • Valoctocogene Roxaparvovec Study Doses 1st Hemophilia Patient with Pre-existing AAV5 Antibodies
  • Workshop on Factor VIII Inhibitors to Take Place This Week at NIH in Maryland
  • IV Self-Infusion Training Significantly Reduced Infections After Joint Replacement Surgery
  • New Hemophilia Therapy Could Be a Game Changer